{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:05:00Z","timestamp":1781103900259,"version":"3.54.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The incidence of diabetes mellitus (DM) is increasing annually, and hearts of patients with DM are more sensitive to myocardial ischemia\/reperfusion (MI\/R) injury. However, the specific mechanisms remain unknown. Through a bibliometric analysis of published research, this study primarily summarizes and clarifies the current status of research on diabetic MI\/R injury.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Publications related to MI\/R injury in DM from January 1, 2004, to July 31, 2024, were obtained by searching the Web of Science Core Collection. The bibliometric method was adopted using Excel 2021, CiteSpace, VOSviewer, Pajek and the R package \u201cBibliometrix.\u201d<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 634 research papers and 221 reviews were published during this period that fit the criteria. The number of annual scientific publications and citations on diabetic MI\/R injury has steadily increased. The majority of these studies were published by 1164 institutions from 70 countries, with China and the United States ranking first and second, respectively, in terms of publication volume. Among the leading institutions in this field, the Air Force Military Medical University, Wuhan University, and the University of Hong Kong were found to occupy the top positions. Keyword analysis reveals that recent research hotspots include antidiabetic agents, anesthetics and extracellular vesicles. Emerging trends such as ferroptosis, mitophagy, and gut microbiota are closely related to future research directions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study provided a detailed overview of the key contributors, institutions, and countries, highlighting the changes and progression of hotspots in diabetic MI\/R injury. China leads the world in paper production; however, international cooperation is essential for enhancing the quality of research. In our study, we found that bibliometric analysis and literature visualization will help investigators gain a deeper understanding of the progress in the research into diabetic MI\/R injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042707","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:02:43Z","timestamp":1749758563000},"page":"e42707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A bibliometric review and visualization of research on myocardial ischemia\/reperfusion injury in patients with diabetes mellitus from 2004 to 2024"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0069-6542","authenticated-orcid":false,"given":"Yunzhao","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Dou","sequence":"additional","affiliation":[{"name":"Sterilization and Supply Center, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-2080","authenticated-orcid":false,"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition.","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes.","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2840-11-67","article-title":"Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.","volume":"11","author":"Miki","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.122.063073","article-title":"Nitrative modification of caveolin-3: a novel mechanism of cardiac insulin resistance and a potential therapeutic target against ischemic heart failure in prediabetic animals.","volume":"147","author":"Meng","year":"2023","journal-title":"Circulation"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.119.042640","article-title":"Small extracellular microvesicles mediated pathological communications between dysfunctional adipocytes and cardiomyocytes as a novel mechanism exacerbating ischemia\/reperfusion injury in diabetic mice.","volume":"141","author":"Gan","year":"2020","journal-title":"Circulation"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12192-022-01273-1","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia\u2013reperfusion injury by enhancing PINK1\/Parkin-mediated mitophagy in type 2 diabetic rats.","volume":"27","author":"Ji","year":"2022","journal-title":"Cell Stress Chaperones"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"1180792","DOI":"10.3389\/fcvm.2023.1180792","article-title":"A bibliometric analysis of myocardial ischemia\/reperfusion injury from 2000 to 2023.","volume":"10","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R8-20250612","first-page":"1","article-title":"Suppression of excessive histone deacetylases activity in diabetic hearts attenuates myocardial ischemia\/reperfusion injury via mitochondria apoptosis pathway.","volume":"2017","author":"Wu","year":"2017","journal-title":"J Diabetes Res"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/ijmm.2017.3014","article-title":"(\u2212)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia\/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.","volume":"40","author":"Wu","year":"2017","journal-title":"Int J Mol Med"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1007\/s11846-024-00738-0","article-title":"How to design bibliometric research: an overview and a framework proposal.","volume":"18","author":"\u00f6zt\u00fcrk","year":"2024","journal-title":"Rev Manag Sci"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","article-title":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.","volume":"17","author":"Zhang","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13880209.2023.2288697","article-title":"Bibliometric analysis of research trends and topic areas in traditional Chinese medicine therapy for lymphoma.","volume":"62","author":"Zhang","year":"2024","journal-title":"Pharm Biol"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"e0295008","DOI":"10.1371\/journal.pone.0295008","article-title":"Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer\u2019s disease: a bibliometric analysis and visualization study from 2002 to 2022.","volume":"19","author":"Kong","year":"2024","journal-title":"PLoS One"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"1335550","DOI":"10.3389\/fnagi.2024.1335550","article-title":"Trends and hotspots in non-motor symptoms of Parkinson\u2019s disease: a 10-year bibliometric analysis.","volume":"16","author":"Li","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"963104","DOI":"10.3389\/fmed.2022.963104","article-title":"Bibliometric and visual analysis of intestinal ischemia reperfusion from 2004 to 2022.","volume":"9","author":"Wan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"1232114","DOI":"10.3389\/fphar.2023.1232114","article-title":"Bibliometric analysis and visualized study of research on autophagy in ischemic stroke.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/pr.107.06002","article-title":"Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning.","volume":"59","author":"Ferdinandy","year":"2007","journal-title":"Pharmacol Rev"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor\u2013dependent and \u2013independent pathways.","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1038\/s41598-024-63528-4","article-title":"The impact of social isolation and loneliness on cardiovascular disease risk factors: a systematic review, meta-analysis, and bibliometric investigation.","volume":"14","author":"Albasheer","year":"2024","journal-title":"Sci Rep"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mvr.2013.08.002","article-title":"Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats.","volume":"90","author":"Lin","year":"2013","journal-title":"Microvasc Res"},{"key":"R22-20250612","first-page":"2441","article-title":"Effects of propofol on LC3II and mTOR\/p\u2011mTOR expression during ischemia\u2011reperfusion myocardium injury in rats with type 2 diabetes mellitus.","volume":"19","author":"Wang","year":"2020","journal-title":"Exp Ther Med"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12653","article-title":"Propofol postconditioning alleviates diabetic myocardial ischemia\u2011reperfusion injuryvia the miR\u2011200c\u20113p\/AdipoR2\/STAT3 signaling pathway.","volume":"25","author":"Huang","year":"2022","journal-title":"Mol Med Rep"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"110188","DOI":"10.1016\/j.biopha.2020.110188","article-title":"Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia\/reperfusion injury in diabetic rats by activating PI3K\/Akt signaling in vivo and in vitro.","volume":"127","author":"Chang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2018.08.006","article-title":"The cardioprotective effect of dexmedetomidine on regional ischemia\/reperfusion injury in type 2 diabetic rat hearts.","volume":"123","author":"Deng","year":"2019","journal-title":"Microvasc Res"},{"key":"R26-20250612","first-page":"1","article-title":"Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress.","volume":"2019","author":"Li","year":"2019","journal-title":"J Diabetes Res"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00592-018-1225-9","article-title":"Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus.","volume":"56","author":"Oh","year":"2019","journal-title":"Acta Diabetol"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jss.2016.03.052","article-title":"Hyperglycemia attenuates remifentanil postconditioning-induced cardioprotection against hypoxia\/reoxygenation injury in H9c2 cardiomyoblasts.","volume":"203","author":"Chen","year":"2016","journal-title":"J Surg Res"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2009.11.032","article-title":"Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.","volume":"628","author":"Kim","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-6576.2012.02748.x","article-title":"Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia\/reperfusion injury by altering glycogen synthase kinase\u20103\u03b2.","volume":"57","author":"Chen","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1535370215622706","article-title":"Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart.","volume":"241","author":"Zhang","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1002\/jcp.30214","article-title":"Hydrogen sulfide restores sevoflurane postconditioning mediated cardioprotection in diabetic rats: Role of SIRT1\/Nrf2 signaling\u2010modulated mitochondrial dysfunction and oxidative stress.","volume":"236","author":"Zhang","year":"2021","journal-title":"J Cell Physiol"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphys.2017.00395","article-title":"Cobalt chloride upregulates impaired HIF-1\u03b1 expression to restore sevoflurane post-conditioning-dependent myocardial protection in diabetic rats.","volume":"8","author":"Wu","year":"2017","journal-title":"Front Physiol"},{"key":"R34-20250612","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2020.00006","article-title":"Deferoxamine treatment combined with sevoflurane postconditioning attenuates myocardial ischemia-reperfusion injury by restoring HIF-1\/BNIP3-mediated mitochondrial autophagy in GK rats.","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41598-019-56897-8","article-title":"Sevoflurane pre-conditioning ameliorates diabetic myocardial ischemia\/reperfusion injury via differential regulation of p38 and ERK.","volume":"10","author":"Xie","year":"2020","journal-title":"Sci Rep"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apha.12874","article-title":"Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats.","volume":"221","author":"Xie","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"R37-20250612","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2016.03.018","article-title":"Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2\/Brg1\/HO-1 signaling.","volume":"779","author":"Gao","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9213034","article-title":"N-acetylcysteine restores sevoflurane postconditioning cardioprotection against myocardial ischemia-reperfusion injury in diabetic rats.","volume":"2016","author":"Lin","year":"2016","journal-title":"J Diabetes Res"},{"key":"R39-20250612","doi-asserted-by":"crossref","first-page":"101884","DOI":"10.1016\/j.arr.2023.101884","article-title":"Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia\/reperfusion injury.","volume":"86","author":"Yang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"708177","DOI":"10.3389\/fphar.2021.708177","article-title":"A SGLT2 inhibitor dapagliflozin alleviates diabetic cardiomyopathy by suppressing high glucose-induced oxidative stress in vivo and in vitro.","volume":"12","author":"Xing","year":"2021","journal-title":"Front Pharmacol"},{"key":"R41-20250612","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/cjpp-2022-0045","article-title":"The effect of dapagliflozin on myocardial ischemia\u2013reperfusion injury in diabetic rats.","volume":"101","author":"Xiong","year":"2023","journal-title":"Can J Physiol Pharmacol"},{"key":"R42-20250612","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/13813455.2023.2252200","article-title":"Dapagliflozin attenuates high glucose-and hypoxia\/reoxygenation-induced injury via activating AMPK\/mTOR-OPA1-mediated mitochondrial autophagy in H9c2 cardiomyocytes.","volume":"130","author":"Tu","year":"2024","journal-title":"Arch Physiol Biochem"},{"key":"R43-20250612","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/JOE-17-0457","article-title":"Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.","volume":"236","author":"Tanajak","year":"2018","journal-title":"J Endocrinol"},{"key":"R44-20250612","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","article-title":"Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis.","volume":"13","author":"Jiang","year":"2022","journal-title":"Protein Cell"},{"key":"R45-20250612","doi-asserted-by":"crossref","first-page":"91","DOI":"10.14740\/cr1194","article-title":"Combination of linagliptin and empagliflozin preserves cardiac systolic function in an ischemia-reperfusion injury mice with diabetes mellitus.","volume":"12","author":"Ideishi","year":"2021","journal-title":"Cardiol Res"},{"key":"R46-20250612","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11239-022-02719-0","article-title":"Empagliflozin activates JAK2\/STAT3 signaling and protects cardiomyocytes from hypoxia\/reoxygenation injury under high glucose conditions.","volume":"55","author":"Zhang","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"R47-20250612","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","article-title":"SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart.","volume":"4","author":"Lim","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"R48-20250612","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4239\/wjd.v9.i9.149","article-title":"Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus.","volume":"9","author":"Zykov","year":"2018","journal-title":"World J Diabetes"},{"key":"R49-20250612","doi-asserted-by":"crossref","first-page":"H131","DOI":"10.1152\/ajpheart.00609.2012","article-title":"Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.","volume":"304","author":"Ye","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R50-20250612","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1440-1681.13450","article-title":"Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia\u2013reperfusion injury in rats with diabetes mellitus type 2.","volume":"48","author":"Bradic","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R51-20250612","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12933-015-0264-6","article-title":"Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.","volume":"14","author":"Murase","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"R52-20250612","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00395-019-0743-0","article-title":"DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome.","volume":"114","author":"Birnbaum","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"R53-20250612","doi-asserted-by":"crossref","first-page":"16735","DOI":"10.3390\/ijms242316735","article-title":"New insights into cardiovascular diseases treatment based on molecular targets.","volume":"24","author":"Wojtasi\u0144ska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R54-20250612","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.3390\/cells10123331","article-title":"Impact of the main cardiovascular risk factors on plasma extracellular vesicles and their influence on the heart\u2019s vulnerability to ischemia-reperfusion injury.","volume":"10","author":"Majka","year":"2021","journal-title":"Cells"},{"key":"R55-20250612","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jcmm.13302","article-title":"Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non\u2010diabetic exosomesin vitro.","volume":"22","author":"Davidson","year":"2018","journal-title":"J Cell Mol Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:02:52Z","timestamp":1749758572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042707","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}